Our latest news
All News
Research
Network News
bioRN News

September 12, 2025
DFG awards Heidelberg research project on early detection of spinal degeneration nearly €250,000 in funding
The aim of the project is to use special quantitative MRI to visualize early changes in the intervertebral disc and enable timely treatment. Ultrashort echo time (UTE) MRI opens up completely new approaches to preventive imaging that are difficult or impossible to achieve with conventional MRI methods. Full text in German below. DFG fördert Heidelberger […]
read more
September 12, 2025
Glioblastoma study shows: Molecular diagnostics could enable targeted therapies without delay
Researchers from Heidelberg University’s Medical Faculty, the German Cancer Research Center (DKFZ), and the National Center for Tumor Diseases (NCT) in Heidelberg have tested the use of targeted drugs in the initial treatment of newly diagnosed glioblastoma, an extremely aggressive brain tumor, in the multicenter study “NCT Neuro Master Match (N2M2)”. Of the five drugs […]
read more
September 12, 2025
Global effort to sequence all life on Earth ramps up
The Earth BioGenome Project is accelerating its efforts tenfold to sequence all life on Earth by 2035 Summary A global collaboration that includes experts at EMBL’s European Bioinformatics Institute (EMBL-EBI) has entered the second phase of its ambitious plan to sequence all 1.67 million known species on Earth by 2035. The Earth BioGenome Project (EBP), a […]
read more
September 12, 2025
New Member: Welcome in our cluster to Quantum-Si Incorporated
Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The Company’s platform enables real-time kinetic-based detection and allows researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating […]
read more
September 12, 2025
New Member: Welcome in our cluster to aimed analytics GmbH
aimed analytics is a cutting-edge SaaS company providing AI-driven biomedical data analysis. Its platform enables fully automated, scalable, and reproducible analysis of complex omics data—without programming skills. Researchers simply upload data and ask questions in natural language. With rapid, cost-efficient workflows, aimed analytics helps biotech, pharma, and academia accelerate discovery and reduce dependency on scarce […]
read more
September 12, 2025
New Member: Welcome in our cluster to Data Powered Therapeutics GmbH
dPTx is building a next-generation platform that transforms protein R&D through automation and structured data. By integrating robotic wet-lab workflows with a propriety smart ELN, they generate ML-ready datasets by design—enabling reproducibility, faster iteration, and scalable discovery. Unlike traditional CROs, they offer more than just services: dPTx provides a datapowered engine for protein production and […]
read more
September 12, 2025
New Member: Welcome in our cluster to BASF SE
BASF creates chemistry for a sustainable future, combining economic success with environmental protection and social responsibility. With about 112,000 employees worldwide, BASF supports customers across nearly all sectors. In pharmaceuticals, BASF delivers high-quality excipients and active ingredients, supporting effective, reliable formulations. With deep expertise in drug manufacturing and delivery, BASF offers solutions for Biopharma, Parenteral, […]
read more
September 11, 2025
aimed analytics secures six-digit first funding and acquires ValueData GmbH
aimed analytics GmbH has successfully closed its first funding round, raising a six-digit investment. At the same time, the company has completed the acquisition of ValueData GmbH, further strengthening its position as a pioneer in AI-driven biomedical data analytics. “Our mission is clear: to shape the future of medicine through the power of data analytics. […]
read more
September 11, 2025
After EMBL: Umlaut.bio and its potential role in drug development
Alumnus Bastian Linder discusses the origin of this start-up and how a tRNA mechanism is helping scientists understand the importance and use of various RNA modifications as they pertain to disease. With just two dots above a letter, the German umlaut can instantly change a word’s pronunciation, its quantity (singular to plural), or even its […]
read more